EGFR and non-small cell lung carcinoma: Interestingly, in T-SCLC that arises from EGFR-mutant NSCLC, exon 19 deletions are present in 64–78% of patients, while L858R mutations are present in only 11–25% of patients [9,11,12,23,43,64].